Haleon Continues Expanding the Richmond Life Sciences Hub

Haleon, a global healthcare company formerly known as GlaxoSmithKline, will invest $54.2 million to upgrade its research & development facility in the City of Richmond. The modernization will enable the company to accommodate innovative technologies and expand its research capabilities. The strategic location of Richmond, with its competitive cost of living and favorable business operating costs, provides an ideal environment for building leading R&D capabilities and attracting world-class talent.​